Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Recruiting now · Not applicable

Conditions studied: Oropharynx Cancer

In brief

This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.

Key facts

Study ID

NCT07033091

Run by

The Institute of Molecular and Translational Medicine, Czech Republic

People needed

20000

Starts

2025-06-01

Expected to finish

2031-03-30

Last updated by the study team

2026-02-13

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants aged 40 years or older at the time of enrollment.
• Individuals who are capable of rinsing the oral cavity by gargling independently.
• Signed informed consent for study participation, molecular-genetic testing, and personal data processing.

You may not qualify if…

• Previously diagnosed head and neck cancer.

Where it is running

• Stomatologická klinika, Fakultní nemocnice u sv. Anny — Brno, Czechia (enrolling)
• Stomatologické centrum ARTDENT s.r.o. — Jihlava, Czechia (enrolling)
• Klinika zubního lékařství Fakultní nemocnice Olomouc — Olomouc, Czechia (enrolling)
• CLINIQ Dejvice — Prague, Czechia (enrolling)
• Masaryk Memorial Cancer Institute — Brno, Czechia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.